Woori Financial Group Revenue Rises: Key Risk Reward Woori Financial Group rated Buy as revenues rose 6.4% YoY and operating margin is 31.7% despite slightly lower net income (-2.0%); stock trades below analyst targets, offering attractive upside. 2026년 07월 24일 English
Hanwha Aerospace Profit Soars 338% YoY – Key Drivers Hanwha Aerospace is rated Buy as profits surged +338% YoY and margins expanded, supported by S&P A- and a $500m overseas bond, offering upside despite defense delivery risks. 2026년 07월 22일 English
Kakao Stock Looks Cheap After Profit Jump: Key Risks Kakao is rated Buy as operating profit surged 66 percent YoY with revenue up 11 percent, offering rerating upside, but net income is flat and risks include labor strain and regulation. 2026년 07월 15일 English
Hana Financial Group Earnings Rise – What Upside Lies Ahead Hana Financial Group is rated Buy as steady YoY revenue and net profit growth continue, supported by a low forward PER 7.5, but upside depends on whether the Cheongna headquarters operational reset improves measurable earnings quality. 2026년 07월 14일 English
Woori Financial Group Stock Rerating Signals: Key Insights Woori Financial looks undervalued at 6.4x forward PER, with steady revenue growth and only a mild net profit dip, plus AI-friendly regulation that could drive re-rating. 2026년 06월 18일 English
Hanwha Group Shares Re-rate on Earnings Momentum: Key Upside Hanwha Group stock gets a Buy rating as revenue rises 28.9% and net profit jumps 79.5%, supported by improved margins and upside to targets. Key risk: one off net profit gains. 2026년 06월 04일 English
Kakao Stock Rallies on Profit Surge: Labor Risk Ahead Kakao is rated Buy as the stock discounts labor fears ahead of June 10, while latest results show strong momentum: operating profit up 66% YoY, revenue up 11%. 2026년 06월 04일 English
Naver Stock Jumps on Defense AI Shift and Nvidia Deal Naver is rated Buy as revenue grows 16.3% YoY with 16.7% operating margin, but net income fell 32.8% due to cost timing. AI factory and defense AI catalysts drive a buy outlook. 2026년 06월 03일 English
Samsung Biologics Shares Rally on Strong Growth: Key Insights Samsung Biologics stays a Buy: despite labor, legal, and quality recall risks, 2026.03 revenue rose 25.8% YoY and operating profit 35.0% YoY, supporting margin resilience and upside. 2026년 06월 02일 English
SK Holdings Shares Look Cheap as Earnings Improve – Key Insight SK Holdings rated Buy as earnings accelerate far faster than revenue, with valuation still conservative despite ETF-driven volatility and short-selling noise. 2026년 05월 28일 English
